Physician profile
Ellen Mady
NPI 1356331441
$6,007.04
in general payments reported to CMS, 2019-2025
42 companies · $1,498 in 2025
The $1,498 reported for 2025 was more than what 91% of Foot Surgery providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $128 · 2021: $216 · 2022: $413 · 2023: $2,471 · 2024: $907 · 2025: $1,498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,938 · Food and Beverage: $1,938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,938.13 |
| Food and Beverage | $1,938.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $2,119.89 | 2023-2025 | |
| Medical Device Business Services, INC. | $691.40 | 2024-2025 | Motoband |
| Arthrex, INC. | $610.48 | 2023 | |
| Stryker Corporation | $455.20 | 2022-2025 | Prostep Mica, Actishield, Augment Injectable |
| Paragon 28, INC. | $190.99 | 2019-2024 | Portfolio, Bun-Yo-Matic |
| Pinnacle, INC | $183.77 | 2021-2023 | |
| Acumed LLC | $176.72 | 2023-2024 | Acumed, Osteomed |
| Kerecis Limited | $149.03 | 2022-2025 | Kerecis Omega3 Surgiclose, Kerecis Surgiclose, Kerecis Omega3 Marigen |
| Arthrosurface Incorporated | $129.00 | 2025 | Arthrosurface Bone Screw |
| Fidia Pharma USA INC. | $92.11 | 2019-2021 | |
| Mimedx Group, INC. | $92.02 | 2024-2025 | |
| Crossroads Extremity Systems, LLC | $77.63 | 2019 | |
| Averitas Pharma INC. | $74.74 | 2023-2024 | Qutenza |
| Abbvie INC. | $68.32 | 2022-2024 | |
| Amniox Medical, INC. | $66.85 | 2019 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $59.74 | 2020 | |
| Trilliant Surgical LLC. | $55.01 | 2019 | |
| Organogenesis INC. | $52.67 | 2020-2023 | Puraply |
| Linvatec Corporation | $51.23 | 2021 | |
| Integra Lifesciences Corporation | $49.79 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $47.12 | 2021-2024 | Motoband, Na |
| Bioventus LLC | $44.57 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $43.13 | 2022 | |
| Paratek Pharmaceuticals, INC. | $39.63 | 2025 | Nuzyra |
| Anika Therapeutics, INC. | $32.28 | 2022 | |
| Osteomed LLC | $29.56 | 2022 | |
| Polynovo North America LLC | $27.63 | 2024 | Novosorb Btm |
| Orthofix Medical, INC. | $27.22 | 2021-2024 | Physio-Stim |
| Horizon Therapeutics Plc | $26.88 | 2023 | Krystexxa |
| Avanos Medical | $24.87 | 2025 | Pnb and Accessories |
| Zyla Life Sciences, INC. | $24.17 | 2019 | |
| Abbott Laboratories | $23.77 | 2024 | Proclaim |
| Vertex Pharmaceuticals Incorporated | $23.74 | 2025 | |
| Cashflow Solutions, LLC | $20.32 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Alfasigma USA, INC. | $18.49 | 2022 | |
| Krystal Biotech INC | $17.04 | 2024 | Vyjuvek |
| Surgenex LLC | $16.96 | 2025 | Surgraft, Surmatrix, Pellograft |
| Melinta Therapeutics, LLC | $16.27 | 2022 | |
| Osiris Therapeutics INC. | $15.18 | 2019 | |
| Dynasplint Systems INC. | $14.04 | 2023 | Dynasplint |
| Baudax Bio INC. | $13.94 | 2022 | |
| Advanced Oxygen Therapy INC. | $13.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Mady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.